Ian Shelton

Ian Shelton is a seasoned professional in venture and business development within the healthcare sector, currently serving as a Senior Venture/Business Development Fellow at CU Innovations and as a Scientific and Business Advisor for RefinedSciences. With a comprehensive background that includes roles as a Senior Venture Fellow with the CU Healthcare Innovation Fund and as a Cancer Pharmacology PhD Candidate at the University of Colorado Anschutz Medical Campus, Ian Shelton has a robust foundation in clinical research and pharmacology. Previous experience includes managing clinical trials in neuroimmunology, where Ian ensured compliance with regulatory standards, and conducting award-winning research on multiple sclerosis. Ian Shelton holds a Doctor of Philosophy in Pharmacology and a Bachelor's degree in Biology and Economics/Finance from prestigious institutions.